Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the osteoporosis treatment market grown over the years?

In recent times, the market size for osteoporosis treatment has seen a consistent growth. The market, which is projected to increase from $13.96 billion in 2024 to $14.62 billion in 2025, will report a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period is credited to several factors including the aging population demographics, hormone replacement therapies, supplementation of calcium and vitamin D, an upsurge in diagnostic tools, and the incorporation of digital health solutions.

What Is the forecasted market size and growth rate for the osteoporosis treatment market?

The market size for osteoporosis therapy is predicted to witness substantial expansion in the forthcoming years. It is anticipated to reach $17.84 billion by 2029, with a compound annual growth rate (CAGR) of 5.1%. The expansion during the predicted period can be credited to factors such as increased sedentary living, a rising occurrence of secondary osteoporosis, the emergence of virtual bone fracture clinics, gene therapy for osteoporosis, and heightened attention to men’s bone health. The upcoming period will also see significant trends like the development of biologics, the use of artificial intelligence and blockchain in bone health records, and the incorporation of machine learning.

Get your osteoporosis treatment market report here!

https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report

What are the major factors driving growth in the osteoporosis treatment market?

The osteoporosis treatment market is anticipated to grow due to the increasing prevalence and incidence of osteoporosis. Osteoporosis is characterized by changes in bone strength and composition, or a decrease in bone mass and mineral density. The standard procedure of most osteoporosis drugs is to decelerate the rate of bone degeneration. Concurrently, hormone-based treatments like estrogen may aid in maintaining bone density, particularly if administered right after menopause. For example, Amgen, a biopharmaceutical company based in the US, estimated in May 2022 that the yearly count of fractures resulting from osteoporosis will surge by 68% to 3.2 million by 2040. Additionally, the National Library of Medicine, another US-based health resource for professionals, recorded in April 2022 that around 549,000 new fragility fractures are reported annually in the UK, with a third of these incidences occurring in men. Predictions state that due to an aging population, this figure is expected to icrease bby 19.6% by 2030. As such, the growing prevalence and incidence of osteoporosis significantly fuel the expansion of the osteoporosis treatment market.

What key areas define the segmentation of the global osteoporosis treatment Market?

The osteoporosis treatment market covered in this report is segmented –

1) By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor

2) By Route Of Administration: Oral, Injectable, Other Routes

3) By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid

2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin Formulations

3) By Hormone Therapy: Estrogen Replacement Therapy, Combination Hormone Therapy (Estrogen And Progesterone)

4) By Selective Estrogen Receptor Modulators (SERMs), Raloxifene, Bazedoxifene

5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide), Other PTHrP Analogues

6) By Rank Ligand (RANKL) Inhibito: Denosumab

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp

What are the top market players propelling the growth of the osteoporosis treatment industry?

Major companies operating in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Teva Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Ltd, Dr. Reddy’s Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., EffRx Pharmaceuticals SA

What are the key trends shaping the future of the osteoporosis treatment market?

To maintain their market position, major players in the osteoporosis treatment market are concentrating on the development of cutting-edge injectable treatments for osteoporosis. These treatments provide a direct solution to prevent bone loss and lessen the risk of fractures in osteoporosis patients via injections for better bone density and improved skeletal health. For example, Apotex Corp., a pharmaceutical company from Canada, introduced the Teriparatide Injection in November 2023. This single-patient pre-filled pen aims to treat osteoporosis and has a 250 mcg/mL concentration with 28 doses of 20 mcg each per pen for daily use. This new product intends to broaden access to cost-effective treatments for the nearly 10 million Americans battling osteoporosis. This development signifies Apotex’s commitment to manufacturing sophisticated generic drugs to ensure patients receive top-tier treatment.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12166

What regions are dominating the osteoporosis treatment market growth?

North America was the largest region in the osteoporosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Refrigerated Goods Trucking Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/refrigerated-goods-trucking-global-market-report

Warehouse Automation Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/warehouse-automation-global-market-report

Autonomous Last Mile Delivery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/autonomous-last-mile-delivery-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: